Hepatitis C Virus Infection Completed Phase 2 Trials for AT-527 (DB16451)

IndicationStatusPhase
DBCOND0033268 (Hepatitis C Virus Infection)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04019717Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) InfectionTreatment